Regeneron (REGN) Highlights Positive Topline Results in Phase 3 Trial
Go back to Regeneron (REGN) Highlights Positive Topline Results in Phase 3 Trial| Regeneron (NASDAQ: REGN) | Delayed: 609.94 +2.01 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $607.93 | 52 Week High | $592.36 | |||
| Open | $612.07 | 52 Week Low | $325.35 | |||
| Day High | $616.24 | P/E | 160.09 | |||
| Day Low | $598.19 | EPS | $3.81 | |||
| Volume | 2,609,260 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 42.38 -0.12 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.50 | 52 Week High | $44.76 | |||
| Open | $42.34 | 52 Week Low | $36.81 | |||
| Day High | $42.47 | P/E | N/A | |||
| Day Low | $41.86 | EPS | $0.00 | |||
| Volume | 4,085,505 | |||||

